Subscribe
Magazine
Videos
Advertise
About Us
Smart Water Summit
Wastewater Summit
Drinking Water
Smart Water
Asset Management
Water Utility Management
Water Reuse
Global Thought Leaders
Podcast
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
WaterWorld Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about DMT Clinical Trial
Recent news which mentions DMT Clinical Trial
Atai's DMT Depression Drug Shows Promise, Prepares For Phase II Trial And Future Collaboration With Pharma Giant
August 14, 2024
Tickers
ATAI
Tags
Market News
Cannabis
treatment/resistant depression
From
Benzinga
Cybin Inc's Two Deuterated Psychedelic Molecules Achieve Positive Topline Clinical Results
January 09, 2024
Tickers
CYBN
NEWS
Tags
News
Penny Stocks
Global
From
Benzinga
Cybin Officially Owns Small Pharma: Plans For New 'International Leader' In Psychedelic Therapeutics
October 23, 2023
Tickers
CYBN
DMTTF
Tags
M&A
Market News
Cannabis
From
Benzinga
Atai Life Sciences Completes Phase 1 Clinical Study Of Oral Film DMT Formulation
October 03, 2023
Tickers
ATAI
Tags
Penny Stocks
News
ATAI
From
Benzinga
Cybin And Fluence Partner To Support EMBARK Training For Phase 3 CYB003 Trial For Depression
September 26, 2023
Tickers
CYBN
Tags
Penny Stocks
Guidance
News
From
Benzinga
Depression Relief: Possible Therapy Boost With DMT & SSRIs, Per Small Pharma Clinical Results
September 26, 2023
Tickers
CYBN
DMTTF
Tags
Psychedelic/Assisted Therapies
CYBN
Management
From
Benzinga
Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety
August 28, 2023
Tickers
CYBN
DMTTF
Tags
CYBN
Short/Acting Psychedelics
Psychedelic/Assisted Therapies
From
Benzinga
Cybin Launches 3-Day Overnight Public Offering For Up To $8.25M, Suspends Prior Purchase Deal
August 01, 2023
Tickers
CYBN
IPOS
Tags
IPOs
Psychedelic/Assisted Therapies
Financing
From
Benzinga
DMT's Clinical Path For Treating TBI And Stroke: Phase 1 Dosing Finished As Phase 2 Gears Up
June 05, 2023
Tickers
AGNPF
Tags
Market News
Cannabis
Markets
From
Benzinga
Novel DMT Compound For Anxiety Shows Clinical Progress: Robust Effects Within 2 Minutes
May 24, 2023
Tickers
CYBN
Tags
Psychedelic/Assisted Therapies
Cannabis
Market News
From
Benzinga
Atai Life Sciences Q1 2023 Results, Pipeline Update On DMT And Psilocybin Clinical Trials
May 11, 2023
Tickers
ATAI
CMPS
Tags
DMT Clinical Trial
Benzinga
Psychedelics
From
Benzinga
This IV Psychedelic-Based Compound Completes Phase 2a Trial, Company Gets Extra IP Coverage
December 22, 2022
Tickers
DMTTF
Tags
major depressive disorder
Cannabis
Market News
From
Benzinga
Psychedelic Therapeutics For Human Stroke: Participant Screening Expects To Begin Soon
November 16, 2022
Tickers
AGNPF
Tags
Psychedelics
Benzinga
DMT Clinical Trial
From
Benzinga
Next-Gen Psychedelic Delivers Promising Results For Treatment-Resistant Depression In Phase 2 Clinical Trial
November 04, 2022
Tickers
BMNDF
Tags
Market News
Cannabis
Markets
From
Benzinga
Tackling Depression With Psychedelics: New Phase 2 Clinical Study Begins At Yale University
October 24, 2022
Tickers
AGNPF
Tags
Psychedelics
Benzinga
Yale University
From
Benzinga
atai's Phase 1 Synthetic DMT-Based Drug Clinical Trial Begins Patient Dosing
October 05, 2022
Tickers
ATAI
Tags
Markets
Market News
Cannabis
From
Benzinga
Clinical Study On DMT Inhaled Product For Treatment-Resistant Depression Completes Dosing Stage
September 23, 2022
Tickers
BMNDF
Tags
Psychedelics
Benzinga
DMT Clinical Trial
From
Benzinga
A Deeper Look At DMT Trials & Studies
June 14, 2022
Tickers
DMT
Tags
Psychedelics
Benzinga
DMT
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.